Lexicon appoints Ivan Cheung to board as Lefkowitz retires after 23 years

LEXICON PHARMACEUTICALS, INC.

Robert J. Lefkowitz, M.D. retires from board effective Dec 2, 2024; no disagreement cited.
Ivan H. Cheung elected to board effective Dec 2, 2024; will serve on audit committee.
Cheung is CEO of NextPoint Therapeutics, former chairman & CEO of Eisai Inc. (18 yrs).
Cheung receives initial option for 186,685 shares vesting over 3 years plus standard director fees.
Company notes catalyst-rich 2025 and beyond in press release.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Robert J. Lefkowitz, M.D.

director

LXRX · LEXICON PHARMACEUTICALS, INC.

Effective: 2024-12-02
Successor: Ivan H. Cheung
Filed: November 20, 2024, 6:59 PM ET

On November 19, 2024, Robert J. Lefkowitz, M.D. notified us of his decision to retire from our board of directors, effective as of December 2, 2024.

Appointed

Ivan H. Cheung

director

LXRX · LEXICON PHARMACEUTICALS, INC.

Effective: 2024-12-02
Filed: November 20, 2024, 6:59 PM ET

On November 19 , 2024, our board of directors elected Ivan H. Cheung to serve as a member of our board of directors, effective as of December 2, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Robert J. Lefkowitz, M.D. retired as director at LEXICON PHARMACEUTICALS, INC..

Action: retired
Role: director

Exact text from the filing

On November 19, 2024, Robert J. Lefkowitz, M.D. notified us of his decision to retire from our board of directors, effective as of December 2, 2024.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

Ivan H. Cheung was elected as director at LEXICON PHARMACEUTICALS, INC..

Action: elected
Role: director

Exact text from the filing

On November 19 , 2024, our board of directors elected Ivan H. Cheung to serve as a member of our board of directors, effective as of December 2, 2024.

View on SEC.gov

LEXICON PHARMACEUTICALS, INC. filing history →

Source: SEC EDGAR

accession 0001062822-24-000062

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.